MICHAEL JOHNSON to Heart Failure
This is a "connection" page, showing publications MICHAEL JOHNSON has written about Heart Failure.
Connection Strength
1.110
-
Use of Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Risk of Dementia in Heart Failure. Am J Alzheimers Dis Other Demen. 2016 08; 31(5):395-404.
Score: 0.198
-
Use of Statins and Risk of Dementia in Heart Failure: A Retrospective Cohort Study. Drugs Aging. 2015 Sep; 32(9):743-54.
Score: 0.194
-
Comparative effectiveness of different angiotensin-converting enzyme inhibitors on the risk of hospitalization in patients with heart failure. J Comp Eff Res. 2012 Mar; 1(2):195-206.
Score: 0.152
-
Comparative effectiveness of individual angiotensin receptor blockers on risk of mortality in patients with chronic heart failure. Pharmacoepidemiol Drug Saf. 2012 Mar; 21(3):233-40.
Score: 0.146
-
Effect of certain angiotensin-converting enzyme inhibitors on mortality in heart failure: a multiple-propensity analysis. Res Social Adm Pharm. 2012 Mar-Apr; 8(2):145-56.
Score: 0.143
-
Adapting the Rx-Risk-V for mortality prediction in outpatient populations. Med Care. 2006 Aug; 44(8):793-7.
Score: 0.103
-
Discharge medication complexity and 30-day heart failure readmissions. Res Social Adm Pharm. 2017 Jul - Aug; 13(4):857-863.
Score: 0.052
-
Depression and anxiety in ambulatory patients with heart failure. Psychosomatics. 2009 Nov-Dec; 50(6):592-8.
Score: 0.032
-
The association of Medicare drug coverage with use of evidence-based medications in the Veterans Health Administration. Ann Pharmacother. 2009 Oct; 43(10):1565-75.
Score: 0.032
-
The association of quality of care and occurrence of in-hospital, treatment-related complications. Med Care. 1999 Feb; 37(2):140-8.
Score: 0.015
-
Comparative Performance of Diagnosis-based and Prescription-based Comorbidity Scores to Predict Health-related Quality of Life. Med Care. 2016 May; 54(5):519-27.
Score: 0.013
-
In-hospital complications among survivors of admission for congestive heart failure, chronic obstructive pulmonary disease, or diabetes mellitus. J Gen Intern Med. 1995 Jun; 10(6):307-14.
Score: 0.012
-
Process of care in Hispanic, black, and white VA beneficiaries. Med Care. 2002 Sep; 40(9):824-33.
Score: 0.005
-
An empirical assessment of the validity of explicit and implicit process-of-care criteria for quality assessment. Med Care. 1999 Aug; 37(8):798-808.
Score: 0.004
-
International Classification of Diseases, 9th Revision, Clinical Modification codes in discharge abstracts are poor measures of complication occurrence in medical inpatients. Med Care. 1997 Jun; 35(6):589-602.
Score: 0.003
-
Identifying complications and low provider adherence to normative practices using administrative data. Health Serv Res. 1995 Oct; 30(4):531-54.
Score: 0.003
-
A method of developing and weighting explicit process of care criteria for quality assessment. Med Care. 1994 Aug; 32(8):755-70.
Score: 0.003